WATERTOWN, Mass. (AP) _ Enanta Pharmaceuticals Inc. (ENTA) on Tuesday reported fiscal second-quarter earnings of $4.1 million.
On a per-share basis, the Watertown, Massachusetts-based company said it had net income of 20 cents.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.
The biotechnology company posted revenue of $39.6 million in the period, which fell short of Street forecasts. Four analysts surveyed by Zacks expected $40.3 million.
Enanta Pharmaceuticals shares have climbed 24% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $87.50, a decline of 16% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENTA at https://www.zacks.com/ap/ENTA